SF3B1 mutations constitute a novel therapeutic target in breast cancer-Reference-Cited by-同舟云学术

SF3B1 mutations constitute a novel therapeutic target in breast cancer

Published:2014-12-22 Issue:4 Volume:235 Page:571-580
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Maguire Sarah L¹,Leonidou Andri¹²,Wai Patty¹²,Marchiò Caterina²³,Ng Charlotte KY³⁴,Sapino Anna²,Salomon Anne‐Vincent⁵⁶,Reis‐Filho Jorge S³⁴,Weigelt Britta³⁴,Natrajan Rachael C¹²

Affiliation:

1. The Breakthrough Breast Cancer Research Centre The Institute of Cancer Research London UK

2. Department of Molecular Pathology The Institute of Cancer Research London UK

3. Department of Medical Sciences University of Turin Turin Italy

4. Department of Pathology Memorial Sloan Kettering Cancer Center New York NY USA

5. Institut Curie Department of Tumour Biology 26 Rue d'Ulm 75248 Paris Cédex 05 France

6. INSERM U934 26 Rue d'Ulm 75248 Paris Cédex 05 France

Funder

Breast Cancer Campaign

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/path.4483

Reference32 articles.

1. Signatures of mutational processes in human cancer

2. APOBEC3B is an enzymatic source of mutation in breast cancer

3. Mutational Processes Molding the Genomes of 21 Breast Cancers

4. Sequence analysis of mutations and translocations across breast cancer subtypes

5. Whole-genome analysis informs breast cancer response to aromatase inhibition

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The splicing factor SF3B1 confers ferroptosis resistance and promotes lung adenocarcinoma progression via upregulation of SLC7A11;Cancer Gene Therapy;2024-08-10

2. Deciphering the role of alternative splicing in neoplastic diseases for immune-oncological therapies;Frontiers in Immunology;2024-04-26

3. SF3B1 mutations provide genetic vulnerability to copper ionophores in human acute myeloid leukemia;Science Advances;2024-03-22

4. Evaluation of Circulating Tumor DNA as a Liquid Biomarker in Uveal Melanoma;Investigative Opthalmology & Visual Science;2024-02-06

5. Pan-Cancer Analysis of ART1 and its Potential Value in Gastric Cancer;Journal of Cancer;2024